Christopher A. Barker, M.D.
Dr. Christopher Barker is a board-certified radiation oncologist who specializes in the treatment of skin cancer (including melanoma) and eye cancer with radiation therapy. He is one of a few radiation oncologists in the country who focus on these diseases. He work closely with a dedicated team of experts. They use advanced radiation techniques to deliver the best possible care to their patients. Some of these techniques include superficial x-ray therapy, electronic and radioisotope-based brachytherapy, stereotactic radiosurgery, and proton therapy. At MSK, they strive to come up with the best solution for even the most rare and challenging problems. He has been a member of the MSK team since 2006. He sees patients at Memorial Hospital in Manhattan and MSK Westchester. Dr. Christopher Barker is an active biomedical researcher. His goal is to develop more effective cancer treatments using radiation therapy. Prior to joining MSK, He was a Howard Hughes Medical Institute Research Scholar in the Radiation Oncology Branch of the National Cancer Institute. There he developed an interest in combining cancer medicines with radiation therapy to make treatment more effective. Along with his colleagues in the Immunology Program and the Departments of Medicine and Surgery at MSK, he has developed several clinical trials. Many of these combine novel targeted and immune therapies with radiation therapy for different cancers.
Interview with Christopher A. Barker
JUMP TO SECTION
(8:09 - 21:57)
Treating lentigo maligna with radiation therapy. What is the consultation process? What is the logistic process for a patient? Why does the treatment have to be delivered in fractionated doses? What is a typical radiation regimen? How long is each treatment session? What are the side effects and when will you expect to see these side effects? What can you do to mitigate the side effects associated with radiation?